SNY - Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers | Benzinga
European Medicines Agency (EMA) will request further clarifications from drugmakers of GLP-1 receptor agonists for diabetes and weight loss, including Novo Nordisk A/S's (NYSE: NVO) popular therapies Ozempic and Wegovy, to investigate suicidal thoughts further.
"While at this point no conclusion can be drawn on a causal association, there are several issues that still need to be clarified," the EMA said in a statement.
EMA's Pharmacovigilance Risk Assessment ...